Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 8, 2012, Pages 754-761

  Kim, Hyung Seok ^a   Yoo, Seon Young ^a   Kim, Kyung Tae ^b   Park, Jong Tae ^a   Kim, Hyun Jong ^a   Kim, Jung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

^b Inje University   (South Korea)

Author keywords

Cancer stem cell; CD133; Nestin; Pancreatic ductal adenocarcinoma; Prognosis

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; INTERMEDIATE FILAMENT PROTEIN; LEUKOCYTE ANTIGEN; NERVE PROTEIN; NESTIN; PEPTIDE; TUMOR MARKER;

AGED; ARTICLE; CANCER STEM CELL; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; SOUTH KOREA; SURVIVAL RATE; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GLYCOPROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PANCREATIC NEOPLASMS; PEPTIDES; PROGNOSIS; REPUBLIC OF KOREA; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84870430608     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Goedegebuure P, Mitchem JB, Porembka MR, Tan MC, Belt BA, Wang-Gillam A, Gillanders WE, Hawkins WG and Linehan DC. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. Curr Cancer Drug Targets 2011; 11: 734-751.
2. Balic A, Dorado J, Alonso-Gomez M and Heeschen C. Stem cells as the root of pancreatic ductal adenocarcinoma. Exp Cell Res 2011.
3. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
4. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-323.
5. Lonardo E, Hermann PC and Heeschen C. Pancreatic cancer stem cells - update and future perspectives. Mol Oncol 2010; 4: 431-442.
6. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
7. Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, Jung S and Lee MC. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 2011; 31: 494-502.
8. Missol-Kolka E, Karbanova J, Janich P, Haase M, Fargeas CA, Huttner WB and Corbeil D. Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate 2011; 71: 254-267.
9. Todaro M, Francipane MG, Medema JP and Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010; 138: 2151-2162.
10. Liu WH, Li R and Dou KF. Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells. Stem Cell Rev 2011; 7: 94-102.
11. Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ and Molven A. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 2008; 8: 48.
12. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F and Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007; 6: 92-97.
13. Moriyama T, Ohuchida K, Mizumoto K, Cui L, Ikenaga N, Sato N and Tanaka M. Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells. Cancer 2010; 116: 3357-3368.
14. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T and Takao S. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 2008; 98: 1389-1397.
15. Vizio B, Mauri FA, Prati A, Trivedi P, Giacobino A, Novarino A, Satolli MA, Ciuffreda L, Camandona M, Gasparri G and Bellone G. Comparative evaluation of cancer stem cell markers in normal pancreas. Oncol Rep 2012; 27: 69-76.
16. Lendahl U, Zimmerman LB and McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595.
17. Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, Vallejo M, Thomas MK and Habener JF. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001; 50: 521-533.
18. Zhang L, Hong TP, Hu J, Liu YN, Wu YH and Li LS. Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells. World J Gastroenterol 2005; 11: 2906-2911.
19. Kawamoto M, Ishiwata T, Cho K, Uchida E, Korc M, Naito Z and Tajiri T. Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol 2009; 40: 189-198.
20. Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R and Hermanova M. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion. J Gastrointestin Liver Dis 2011; 20: 389-396.
21. Carriere C, Seeley ES, Goetze T, Longnecker DS and Korc M. The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc Natl Acad Sci USA 2007; 104: 4437-4442.
22. Kim HS, Youm HR, Lee JS, Min KW, Chung JH and Park CS. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer. Lung Cancer 2003; 42: 163-170.
23. Shimizu K, Itoh T, Shimizu M, Ku Y and Hori Y. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas. Pancreas 2009; 38: e207-214.
24. Schittenhelm J, Simon P, Harter PN, Zachskorn C, Schlaszus H, Rottger F, Winkels M, Weller M, Meyermann R and Mittelbronn M. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms. Histopathology 2011; 58: 739-749.
25. Corbeil D, Roper K, Fargeas CA, Joester A and Huttner WB. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2001; 2: 82-91.
26. Han CW, Min BW, Kim Y, Jeong EH, Park CS, Woo YJ, Kim HS and Lee MC. Immunohistochemical analysis of developmental neural antigen expression in the balloon cells of focal cortical dysplasia. J Clin Neurosci 2011; 18: 114-118.
27. Wang YH, Li F, Luo B, Wang XH, Sun HC, Liu S, Cui YQ and Xu XX. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma 2009; 56: 371-378.
28. Hu G, Li F, Ouyang K, Xie F, Tang X, Wang K, Han S, Jiang Z, Zhu M, Wen D, Qin X and Zhang L. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line. Int J Oncol 2011.
29. Mueller MT, Hermann PC, Witthauer J, Rubio-Viqueira B, Leicht SF, Huber S, Ellwart JW, Mustafa M, Bartenstein P, D'Haese JG, Schoenberg MH, Berger F, Jauch KW, Hidalgo M and Heeschen C. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 2009; 137: 1102-1113.
30. Ng SSW, Tsao MS, Chow S and Hedley DW. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res 2000; 60: 5451-5455.
31. Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z and Fang J. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 2008; 27: 85.
32. Ohike N, Sato M, Hisayuki T, Imataka H, Sato S, Wada Y, Saito K, Takahashi M, Tajiri T, Kunimura T and Morohoshi T. Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors. Pathol Int 2007; 57: 589-593.
33. Zlobec I, Terracciano L, Jass JR and Lugli A. Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch 2007; 451: 763-769.
34. Matsuda Y, Naito Z, Kawahara K, Nakazawa N, Korc M and Ishiwata T. Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther 2011; 11: 512-523.